MR

Medicinal Research Reviews

Medicinal Research Reviews is a top-ranked medicinal chemistry journal that publishes timely critical reviews and opinion-based articles covering the full range of medicinal research to which authors have made significant contributions.

Looking to publish in Medicinal Research Reviews? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Impact Factor 11.6
Quartile Q1
Open Access Type Hybrid
ISSN 0198-6325
eISSN 1098-1128
Invitation Only No
Cost Range Open access article publication charge (APC) applies and may be covered by an author's institution.

Submission Instructions

Medicinal Research Reviews accepts the following article types. Click on an article type to view submission instructions.

Mini Reviews

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 250 words.
Manuscript Main text must be 3,500 words excluding the abstract and references. Main text must begin with an Introduction and end with an Outlook section, and it may be organized by subheadings. Manuscript must include up to five keywords.
References Reference list should include 40 to 80 references. References may be submitted in any consistent style, but if formatted they should use AMA style. If formatted, references must be numbered consecutively in order of appearance with in-text citations as Arabic superscript numerals.
Figures & Tables Manuscript may be submitted as a single file including figures and tables or as separate files. Figures and tables must have legends.
Reformat to Medicinal Research Reviews using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required for Review Articles. Abstract must be 250 words.
Manuscript Main text must be 10,000 words excluding the abstract and references. Main text should begin with an Introduction, may be organized by subheadings, and should end with an Outlook section commenting on the future direction of the field. Manuscript must include up to five keywords and a brief third-person biosketch of 250 words or less for each author.
References Review Articles should include 70 or more references. AMA style should be used if references are formatted. If references are formatted, they should be numbered consecutively in order of appearance and cited in the text using Arabic superscript numerals.
Figures & Tables Manuscript may be submitted as a single file including figures and tables or as separate files, although figures should be supplied as separate files. Figures and tables must have legends.
Reformat to Medicinal Research Reviews using Livewrite Premium

Insights

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract should be included. Abstract should be 250 words.
Manuscript Main text should be 1,500 words, excluding abstract and references. Manuscript must be written as continuous text with no subheadings. Manuscript should include up to five keywords.
References References should total 5–20. AMA style should be used if references are formatted. If formatted, references must be numbered consecutively in order of appearance and cited in the text with Arabic superscript numerals.
Figures & Tables Manuscript may be submitted as a single file including figures and tables or as separate files. Figures and tables must have legends.
Reformat to Medicinal Research Reviews using Livewrite Premium

Recent Publications

Issue Information

-

10.1002/med.70062
View Publication

Targeting P2Y 14 Receptor in Inflammatory and Metabolic Diseases: From Pathophysiology to Therapeutic Inhibitors

Shufan Ren, Kai Wang, Jialiang Wang, Jiatong Xie, Jiayi Zhou, Wenjie Hou, Ruiqing Tong, Qinghua Hu, Huanqiu Li

10.1002/med.70066
View Publication

Selective Targeting of STAT6: Recent Advances and Future Perspectives

Hua Liu, Feihai Ma, Zexu Wang, Zhiyu Li, Jinlei Bian, Zeli Yuan, Tizhi Wu

10.1002/med.70069
View Publication

Plasmepsins as Antimalarial Drug Targets—Then, Now, and the Future

Brad E. Sleebs

10.1002/med.70065
View Publication

Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria

Wisam A. Dawood, Jacinta R. Macdonald, Christian Anzenhofer, Tina S. Skinner‐Adams, Robert C. Reid, Thomas Kurz, David P. Fairlie, Katherine T. Andrews

10.1002/med.70055
View Publication

Frequently asked questions

How long does it take to publish?

Median submission to first decision is 23 days, median submission to acceptance is 251 days, and median acceptance to publication is 18 days.

Reformat to Medicinal Research Reviews using Livewrite Premium

Is a cover letter required?

A cover letter is not specified. Submissions require an invitation from the Editor or a completed Review Summary Sheet.

Reformat to Medicinal Research Reviews using Livewrite Premium

What are the publication costs?

Open access article publication charge (APC) applies and may be covered by an author's institution.

Reformat to Medicinal Research Reviews using Livewrite Premium

Research Topics

Computational Drug Discovery Methods Receptor Mechanisms and Signaling Chemical Synthesis and Analysis HIV/AIDS drug development and treatment Cancer therapeutics and mechanisms Monoclonal and Polyclonal Antibodies Research Click Chemistry and Applications Neuropeptides and Animal Physiology Neuroscience and Neuropharmacology Research Pharmacological Receptor Mechanisms and Effects Peptidase Inhibition and Analysis Animal Ecology and Behavior Studies Protein Degradation and Inhibitors Biochemical and Molecular Research RNA Interference and Gene Delivery Cholinesterase and Neurodegenerative Diseases Plant and fungal interactions Histone Deacetylase Inhibitors Research Diverse Scientific and Economic Studies Glycosylation and Glycoproteins Research Adenosine and Purinergic Signaling Drug Transport and Resistance Mechanisms Autophagy in Disease and Therapy Ubiquitin and proteasome pathways Inflammatory mediators and NSAID effects